All In MedTech

FDA Clearance Tracker · P060037-S073

NexGen LPS-Flex/LPS Mobile Bearing Knee System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 15, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 15, 2021

Approved

Time to decision

168 days

Received Jun 30, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P060037-S073
Device name
NexGen LPS-Flex/LPS Mobile Bearing Knee System
Applicant
Zimmer, Inc.
Applicant location
Warsaw, IN
Received
Jun 30, 2021
Decided
Dec 15, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P060037

Device type

Device class
Class III

Every decision under product code NJL

FDA's approval statement

As written in FDA's record.

Approval to modify the labeling to reflect the findings of the final Post-Approval Study (PAS) report.

Source documents

Other decisions for Zimmer, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.